#United States #San Diego #Radicle Science #Bill Bae #Jackie Bowen

Radicle Science Expands Leadership Team to Accelerate Growth

Radicle Science, a pioneering company in health technology, is enhancing its executive bench to further its mission of bringing clinical evidence and precision-based solutions to the wellness sector. The appointment of Bill Bae as Chief Commercial Officer and Jaclyn "Jackie" Bowen as Senior Vice-President of Strategic Initiatives marks a significant step in the company's growth trajectory.

Who Are the New Leaders?

Bill Bae

Bill Bae joins Radicle Science with a wealth of international expertise in commercial strategy and marketing across various industries, including nutrition, health, wellness, life sciences, and biotech. His career spans reputable Fortune 100 companies and startups, where he successfully developed and executed commercial strategies and built high-performative teams. Bae's professional history includes roles at leading organizations such as ADM and Thermo Fisher Scientific. He stated, "I joined Radicle because I believe the future of wellness is going to be precise, personalized, and proven—and Radicle is uniquely equipped to deliver on that." His vision is to eliminate barriers in clinical research and bring effective health solutions to a wider audience.

Jaclyn Bowen

Jaclyn Bowen brings her extensive experience in food safety, certification, and consumer advocacy to Radicle Science. Previously the executive director of the Clean Label Project Foundation, Bowen specializes in reducing contaminants in food and consumer products. With a strong background in compliance systems and product safety, she has held significant roles at various organizations, including the World Health Organization. Bowen remarks, "Joining Radicle Science is a natural continuation of my journey challenging the status quo. I'm inspired by the mission to deliver rigorous, equitable, and radically accessible clinical evidence to redefine natural products."

What It Means for Radicle Science

The addition of Bae and Bowen is prompted by an increasing focus on transparency and consumer advocacy, which Radicle Science believes is essential for success in the evolving health tech landscape. Co-founders Pelin Thorogood and Dr. Jeff Chen expressed confidence, stating, "World-class commercial leadership and uncompromising consumer advocacy are exactly what this moment demands." Together, Bae and Bowen will drive partnerships and elevate standards, transforming clinical evidence into a significant competitive advantage.

Growth Milestones

As Radicle Science celebrates its fifth anniversary, the company reflects on its remarkable growth, having doubled the number of clinical trials annually and expanded its innovation pipeline substantially. It proudly holds the distinction of being recognized as No. 1040 on the Inc. 5000 list of fastest-growing private companies. Key initiatives that highlight this growth include the launch of Radicle Discovery Gen 2 Trials, which aim to expedite product validation and market strategies. Furthermore, the company is actively participating in high-profile conferences globally, speaking on topics surrounding precision health and artificial intelligence.

A Vision for the Future

Radicle Science's commitment to bridging the gap between consumer trust and scientific validation has positioned it as a leader in health tech innovation. By including a diverse set of individuals in clinical trials, the company endeavors to advance health equity and set new benchmarks in evidence-based healthcare solutions. Since its establishment, Radicle Science has conducted trials on wellness products with nearly 75,000 participants, offering insights that challenge traditional perceptions of natural product efficacy.

As it moves forward, Radicle Science continues to aim for transformational changes in how natural health products are perceived and validated, ensuring that rigorous scientific evidence becomes the standard within the industry.